Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 6 , Pages 1023-1038, December 2008

Receptor tyrosine kinase inhibitors in thyroid cancer

  • Massimo Santoro, MD, PhD (Professor of Pathology)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +39-081-7463056; Fax: +39-081-7463037.

Istituto di Endocrinologia ed Oncologia Sperimentale CNR, 80131 Naples, Italy c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare, Universita' Federico II, 80131 Naples, Italy

Istituto di Endocrinologia ed Oncologia Sperimentale CNR, 80131 Naples, Italy c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare, Universita' Federico II, 80131 Naples, Italy

Dipartimento di Studi delle Istituzioni e dei Sistemi Territoriali, Universita' ‘Parthenope’, 80133 Naples, Italy

Dipartimento di Biologia e Patologia Cellulare e Molecolare, ‘L. Califano’, Università Federico II, via S. Pansini 5, 80131 Naples, Italy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(08)00109-7

doi:10.1016/j.beem.2008.09.012

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 6 , Pages 1023-1038, December 2008

Article Tools

* Image Usage & Resolution